A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week follow-up with his family doctor for suture removal, he describes ongoing pain. Can prescribers avoid contributing to opioid use disorder? Is a renewal of opioid appropriate, potentially dangerous, or both? Read more …
Therapeutics Letter #125: Can prescribers avoid contributing to opioid use disorder? (Issue 125, January-February 2020) has now been posted on the TI website. It can be accessed through this short link: https://ti.ubc.ca/letter125
If you enjoyed reading this post, you may also like reading more about opioid research. Or, visit the REDONNA study at Dr Rita McCracken’s home page.